Unlock instant, AI-driven research and patent intelligence for your innovation.

Construction method and application of Nur77 GFP Jurkat report cell line

A cell line and reporting technology, applied in DNA/RNA fragments, animal cells, vertebrate cells, etc., which can solve problems such as high cost, high risk, and inability to screen and optimize CAR sequences early

Pending Publication Date: 2021-06-04
HRAIN BIOTECHNOLOGY CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, the CAR-T products developed by major companies are generally only roughly verified at the cellular level (that is, the ability of CAR-T to kill target cells) at the early stage. After being verified to be effective, they can enter animal experiments and clinical trials. The final effect of CAR can only be confirmed after the results of clinical trials are obtained. The cost is high and the risk is high, and CAR sequences cannot be screened and optimized in the early stage. Therefore, the field of cell therapy urgently needs a set of in vitro screening methods that can quickly evaluate CAR functions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of Nur77 GFP Jurkat report cell line
  • Construction method and application of Nur77 GFP Jurkat report cell line
  • Construction method and application of Nur77 GFP Jurkat report cell line

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1: sgRNA screening

[0030] sgRNA design and synthesis

[0031]In order to more efficiently recombine a piece of exogenous gene GFP before the stop codon of Nur77 to directly reflect the gene expression of NUR77, CRISPR gene editing technology was used to improve the efficiency of gene recombination. The sgRNA design was carried out through the online sgRNA design website https: / / zlab.bio / guide-design-resources, and the sgRNA sequence is shown in Table 1. Put all the sgRNA sequences generated by the website (indicated by XXXXXXXXXXXXXXXXXXXX) into the sgRNA backbone sequence 5'TTCTAATACG ACTCACTATA XXXXXXXXXXXXXXXXXXXX GTTTTAGAG CTAGAAATAG CAAGTTAAAATAAGGCTAGT CCGTTATATCAA CTTGAAAAAG TGGCACCGAG TCGGTGCTTT T3 ' Use the NEB T7 transcription kit to transcribe into functional sgRNA. The transcribed sgRNA sequence is 5′ GUGCAACCUUCAUUUCCCUGCYYYYYYYYYYYYYYYYYYYYAAUAGCAAGUUAAAAUAAGGCUAG UCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU 3′

[0032] Table 1. Nur77 exon 8 sgRN...

Embodiment 2

[0038] Embodiment 2: exogenous DNA template (donor DNA) vector construction

[0039] PCR of the left homology arm fragment: using Jurkat T cell DNA as a template, add the left homology arm forward primer LHA_fwd: atccccgggtaccgagctcgGATCCTCCTGTCTCAGCCTC, and reverse primer Mut-LHA-R2: ctccggagccGAAGGGCAGCGTGTCCATGAAGATCTTGTCAAT GATTGGCGGCGGTGGCACCAAGTCCTCCAGCTTG for PCR with TOYOBO high-fidelity KODFX kit , to obtain the 880bp left homology arm fragment.

[0040] Exogenous insert fragment P2A-GFP fragment PCR: use the plasmid pCCL-luciferase-P2A-GFP containing P2A-GFP as a template, add forward primer GFP_fwd: gctgcccttcGGCTCCGGAGAGGGACGG reverse primer GFP_rev: caggcaggggTTACTTGTACAGCTCGTCCATGCC, use TOYOBO high-fidelity KOD FX kit By PCR, a 783bp P2A-GFP fragment was obtained.

[0041] Right homology arm fragment PCR: using Jurkat T cell DNA as a template, add right homology arm forward primer RHA_fwd: gtacaagtaaCCCCTGCCTGGGAACACG, and reverse primer RHA_rev: ttgtaaaacgacgg...

Embodiment 3

[0047] Example 3. Jurkat Nur77-GFP cell line construction

[0048] 1) RNP and donor DNA delivery: Mix 250ng N8-9sgRNA and 1μg Cas9 protein and incubate at room temperature for 15min to form RNP; then add 1μg donor DNA, use Thermo Fisher Neon electroporation instrument, follow neon electroporation parameters 1700V / 10ms / 3 pulses In the electroporation method, the mixture of RNP and donor DNA was electroporated into 5*10^5 JurkatT cells. Immediately after electroporation, the cells were transferred to a preheated 24-well plate and cultured in medium for 72 h.

[0049] 2) Detection of Nur77-GFP functional expression in cell pool: CD3 signaling pathway can activate Jurkar T and promote Nur77 expression. Since Nur77 and GFP share the Nur77 promoter, only cells with correct recombination will produce GFP signal, and the degree of GFP expression also represents Nur77 expression levels. 72 hours after electroporation, CD3 antibody OKT3 was added to 4*10^5 cells, and the final concent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an Nur77-GFP Jurkat report cell line and a construction method thereof. On one hand, the report cell ine and the construction method thereof have great significance for the specific function evaluation of CAR (Chimeric Antigen Receptor) or TCR (Thyristor Cell Receptor), and on the other hand, the invention provides sgRNA (Single Guide Ribonucleic Acid) of specific targeting Nur77, a targeting sequence of the sgRNA and left and right homologous arm sequences of a donor DNA (Deoxyribose Nucleic Acid) vector.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular to a method for constructing a Nur77-GFP Jurkat reporter cell line and its use. Background technique [0002] Tumor (cancer) is the biggest killer of public health. Immunotherapy is considered to be the most promising means to overcome cancer. Chimeric antigen receptor T cell (CAR-T) therapy in immunotherapy is because of its excellent performance in the field of hematological tumor treatment. The revolutionary breakthrough was rated as the top ten scientific and technological breakthroughs in the world in 2013 by the internationally authoritative "Science" magazine. CAR-T therapy has developed rapidly at home and abroad in recent years. Up to now, there are three CAR-T products that have been approved for marketing in the world, namely Novartis’ Kymrial (mainly used for B-cell acute lymphoblastic leukemia) treatment), and Gilead's (Kite) Yescarta (mainly for the treatment of B...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/10C12N15/85C12N15/65C12N15/113C12N15/11C12N9/22
CPCC07K14/70567C12N5/0636C12N9/22C12N15/1138C12N15/65C12N15/85C12N2510/00C12N2310/20
Inventor 刘芳周杰王赛赛
Owner HRAIN BIOTECHNOLOGY CO LTD